----
Current ValuationThe current P/E ratio is -16.02, within the reasonable range, cheaper than 39.34% of the time in the past 5 years, and the industry ranks 13/16, the industry Median 12.83.
-16.02xP/E
HK$35.02Stock price
HK$-2.19Earnings per share
-16.02xP/E
Stock priceHK$35.02Earnings per shareHK$-2.19
Historical Valuation
P/E ratioTypical rangeMedian
- P/E ratio
- -18.56x
- Typical range
- -29.72x–0.94x
Peer P/E ratio Comparison
It displays how the company's P/E ratio compares to top companies within its industry.
Industry median 12.83x
012243648
Industry P/E ratio Comparison
This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
Industry median 12.83x
0x10x20x30x40x50x
| Name/Symbol | |||
|---|---|---|---|
02945HKGENSCRIPT B-2K | -15.51x | -- | HK$77.42B |
01548HKGENSCRIPT BIO | -16.02x | 95.10% | HK$79.97B |
03347HKTIGERMED | -68.80x | -- | HK$32.43B |
02228HKXTALPI | -108.18x | 167.69% | HK$26.27B |
03696HKINSILICO | -9.03x | 100.56% | HK$21.06B |
02576HKTAIMEI TECH | -30.52x | -- | HK$2.29B |
08225HKC HEALTH GP | -4.03x | -- | HK$65.69M |
Risk Warning
Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.
